Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint

Thermo FisherIs Thermo Fisher Scientific (TMO) Fairly Priced After Recent Share Price Rebound? - simplywall.st

10x Genomics Blog10x Genomics Launches Atera Platform for Spatial Biology - Intellectia AI

Lonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract strength enough for steady U.S. inves - AD HOC NEWS

10x Genomics Blog10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - PR Newswire

10x Genomics Blog10x Genomics Unveils Atera Spatial Platform at AACR Meeting - Genetic Engineering and Biotechnology News

10x Genomics BlogOvervalued Tech Stocks? Texas Instruments, Jabil, 10x Genomics Face Scrutiny - News and Statistics - IndexBox

AgilentAgilent Stock Performance & Valuation Analysis 2026 | Business Review - News and Statistics - IndexBox

Lonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract dominance strong enough to unlock new - AD HOC NEWS

Thermo FisherThermo Fisher Scientific launches Applied Biosystems™ PowerFlex™ Thermal Cycler - BioSpectrum India

Lonza NewsLonza Group AG stock (CH0013841017): Is biopharma contract demand strong enough to drive sustained u - AD HOC NEWS

Thermo FisherNinety One North America Inc. Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat

FierceBiotechAACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’